The bank's massive wealth management business will be helped by high stock market values in the fourth quarter, which inflates the management fees it collects.
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.
The Federal Trade Commission has filed a lawsuit against agricultural equipment giant Deere & Company, alleging it holds a monopoly on repair services.
Goldman's fourth-quarter results will give investors a preview of what to expect this year, as investment banking and trading fees are both expected to rise.
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.